Radiopharmaceuticals Startup Secures $175M Funding
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
- Latest
- Trending
Aktis Oncology, a radiopharmaceuticals startup, raises $175M to advance targeted cancer treatments, focusing on specific tissues.
Pharma giant Bristol Myers Squibb acquires RayzeBio for $4.1 billion, expanding its presence in the oncology sector and strengthening its ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.